{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:49:52Z","timestamp":1771019392229,"version":"3.50.1"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["B2\/202\/P3\/HELICON"],"award-info":[{"award-number":["B2\/202\/P3\/HELICON"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Introduction<\/jats:title><jats:p>Cancer causes a substantial burden to our society, both from a health and an economic perspective. To improve cancer patient outcomes and lower society expenses, early diagnosis and timely treatment are essential. The recent COVID-19 crisis has disrupted the care trajectory of cancer patients, which may affect their prognosis in a potentially negative way. The purpose of this paper is to present a flexible decision-analytic Markov model methodology allowing the evaluation of the impact of delayed cancer care caused by the COVID-19 pandemic in Belgium which can be used by researchers to respond to diverse research questions in a variety of disruptive events, contexts and settings.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>A decision-analytic Markov model was developed for 4 selected cancer types (i.e. breast, colorectal, lung, and head and neck), comparing the estimated costs and quality-adjusted life year losses between the pre-COVID-19 situation and the COVID-19 pandemic in Belgium. Input parameters were derived from published studies (transition probabilities, utilities and indirect costs) and administrative databases (epidemiological data and direct medical costs). One-way and probabilistic sensitivity analyses are proposed to consider uncertainty in the input parameters and to assess the robustness of the model\u2019s results. Scenario analyses are suggested to evaluate methodological and structural assumptions.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Discussion<\/jats:title><jats:p>The results that such decision-analytic Markov model can provide are of interest to decision makers because they help them to effectively allocate resources to improve the health outcomes of cancer patients and to reduce the costs of care for both patients and healthcare systems. Our study provides insights into methodological aspects of conducting a health economic evaluation of cancer care and COVID-19 including insights on cancer type selection, the elaboration of a Markov model, data inputs and analysis.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0288777","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T17:38:29Z","timestamp":1698687509000},"page":"e0288777","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4679-8236","authenticated-orcid":true,"given":"Yasmine","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4242-9062","authenticated-orcid":true,"given":"Robby","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brecht","family":"Devleesschauwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Gadeyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Gorasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolande","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko","family":"Speybroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-7636","authenticated-orcid":true,"given":"Nancy","family":"Vandamme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miet","family":"Vandemaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Van den Borre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Vandepitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Vanthomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freija","family":"Verdoodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"pone.0288777.ref001","unstructured":"ECIS. Estimates of cancer incidence and mortality in 2020, for all cancer sites. 2022 [Cited 2022 April 10]; Available from: https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0-0$1-AEE$2-All$4-1,2$3-All$6-0,85$5-2020,2020$7-7$CEstByCancer$X0_8-3$CEstRelativeCanc$X1_8-3$X1_9-AE27$CEstBySexByCancer$X2_8-3$X2_-1-1"},{"key":"pone.0288777.ref002","author":"GLOBOCAN","year":"2020","journal-title":"Summary cancer statistics for Europe in 2020"},{"key":"pone.0288777.ref003","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease (GBD). 2022 [Cited 2022 April 5]; Available from: https:\/\/vizhub.healthdata.org\/gbd-compare\/"},{"key":"pone.0288777.ref004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","article-title":"The cost of cancer in Europe 2018","volume":"129","author":"T Hofmarcher","year":"2020","journal-title":"Eur J Cancer"},{"key":"pone.0288777.ref005","author":"World Health Organization (WHO).","year":"2022","journal-title":"Promoting Cancer Early Diagnosis"},{"key":"pone.0288777.ref006","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","author":"TP Hanna","year":"2020","journal-title":"BMJ"},{"key":"pone.0288777.ref007","doi-asserted-by":"crossref","first-page":"101880","DOI":"10.1016\/j.ejon.2020.101880","article-title":"Awareness and help-seeking for early signs and symptoms of lung cancer: A qualitative study with high-risk individuals.","volume":"50","author":"MM Saab","year":"2021","journal-title":"Eur J Oncol Nurs"},{"key":"pone.0288777.ref008","unstructured":"National Health Service (NHS). Achieving World-Class Cancer Outcomes: A Strategy for England 2015\u20132020 \u2013Progress Report 2016\u201317. 2017; Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2017\/10\/national-cancer-transformation-programme-2016-17-progress.pdf"},{"issue":"1","key":"pone.0288777.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00097-5","article-title":"Global disparities in access to cancer care","volume":"2","author":"I dos-Santos-Silva","year":"2022","journal-title":"Commun Med"},{"issue":"3","key":"pone.0288777.ref010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/tbm\/ibx079","article-title":"Cancer care coordination: opportunities for healthcare delivery research.","volume":"8","author":"SJ Weaver","year":"2018","journal-title":"Transl Behav Med"},{"issue":"10","key":"pone.0288777.ref011","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"R Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"pone.0288777.ref012","author":"World Health Organization (WHO)","year":"2020","journal-title":"Maintaining essential health services: operational guidance for the COVID-19 context, interim guidance"},{"issue":"3","key":"pone.0288777.ref013","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(20)30743-9","article-title":"The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study","volume":"22","author":"K Spencer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"7","key":"pone.0288777.ref014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/GO.20.00639","article-title":"Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.","author":"R Riera","year":"2021","journal-title":"JCO Glob Oncol."},{"issue":"5","key":"pone.0288777.ref015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41571-020-0362-6","article-title":"Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic.","volume":"17","author":"TP Hanna","year":"2020","journal-title":"Nat Rev Clin Oncol."},{"issue":"8","key":"pone.0288777.ref016","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.","volume":"21","author":"C Maringe","year":"2020","journal-title":"Lancet Oncol."},{"issue":"11","key":"pone.0288777.ref017","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S1470-2045(21)00493-9","article-title":"Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.","volume":"22","author":"COVIDSurg Collaborative","year":"2021","journal-title":"Lancet Oncol."},{"key":"pone.0288777.ref018","article-title":"Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.","author":"HM Peacock","year":"2021","journal-title":"ESMO Open [Internet]."},{"key":"pone.0288777.ref019","author":"Belgian Cancer Registry (BCR)","year":"2022","journal-title":"Short report\u2014Cancer in Belgium, 2020"},{"issue":"6","key":"pone.0288777.ref020","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/cancers15061753","article-title":"Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019\u20132021).","volume":"15","author":"G Garrido-Cantero","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"pone.0288777.ref021","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clbc.2023.01.001","article-title":"Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic.","volume":"23","author":"K Adachi","year":"2023","journal-title":"Clin Breast Cancer."},{"key":"pone.0288777.ref022","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejca.2021.04.019","article-title":"Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK","volume":"152","author":"A Gheorghe","year":"2021","journal-title":"Eur J Cancer"},{"key":"pone.0288777.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","author":"AH Briggs","year":"2006","journal-title":"Decision Modelling for Health Economic Evaluation"},{"issue":"1","key":"pone.0288777.ref024","first-page":"10","article-title":"Explanation and Elaboration: A report of the ISPOR CHEERS II Good Practices Task Force.","volume":"25","author":"CHEERS","year":"2022","journal-title":"Value Health."},{"key":"pone.0288777.ref025","unstructured":"Belgian Cancer Registry (BCR). Cancer Burden In Belgium, 2004\u20132019. 2022 [Cited 2022 June 2]; Available from: https:\/\/kankerregister.org\/media\/docs\/publications\/Shortreport_Cancerburden_2004-2019.pdf"},{"issue":"12","key":"pone.0288777.ref026","doi-asserted-by":"crossref","first-page":"e2030072","DOI":"10.1001\/jamanetworkopen.2020.30072","article-title":"Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers","volume":"3","author":"EB Cone","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0288777.ref027","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov Models in Medical Decision Making: A Practical Guide.","volume":"13","author":"F Sonnenberg","year":"1993","journal-title":"Med Decis Mak Int J Soc Med Decis Mak."},{"key":"pone.0288777.ref028","first-page":"351","article-title":"Markov Models and Cost Effectiveness Analysis: Applications in Medical Research. In: MIT Critical Data, editor. Secondary Analysis of Electronic Health Records","author":"M Komorowski","year":"2016","journal-title":"Internet]. Cham: Springer International Publishing"},{"key":"pone.0288777.ref029","article-title":"On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers.","author":"A Carta","year":"2020","journal-title":"Front Public Health [Internet]."},{"issue":"6","key":"pone.0288777.ref030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","article-title":"State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.","volume":"15","author":"U Siebert","year":"2012","journal-title":"Value Health.Sep 1"},{"issue":"10","key":"pone.0288777.ref031","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.21873\/anticanres.13772","article-title":"Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer","volume":"39","author":"K Neki","year":"2019","journal-title":"Anticancer Res"},{"issue":"9","key":"pone.0288777.ref032","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/DCR.0000000000001158","article-title":"Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population","volume":"61","author":"E Osterman","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"pone.0288777.ref033","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jamadermatol.2019.0440","article-title":"Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor","volume":"155","author":"LA von Schuckmann","year":"2019","journal-title":"JAMA Dermatol"},{"key":"pone.0288777.ref034","author":"The National Institute for Health and Care Excellence (NICE).","year":"2022","journal-title":"Definition of Quality-adjusted life year."},{"issue":"12","key":"pone.0288777.ref035","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1007\/s11136-019-02300-y","article-title":"A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review.","volume":"28","author":"L Van Wilder","year":"2019","journal-title":"Qual Life Res.Dec 1"},{"key":"pone.0288777.ref036","doi-asserted-by":"crossref","first-page":"675523","DOI":"10.3389\/fpubh.2021.675523","article-title":"Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.","volume":"9","author":"T Zhou","year":"2021","journal-title":"Front Public Health."},{"issue":"6","key":"pone.0288777.ref037","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40273-018-0623-8","article-title":"Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries.","volume":"36","author":"MF Janssen","year":"2018","journal-title":"Pharmacoeconomics."},{"key":"pone.0288777.ref038","author":"EuroQol"},{"issue":"Suppl 3","key":"pone.0288777.ref039","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1111\/1475-6773.13048","article-title":"Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.","volume":"53","author":"L Lei","year":"2018","journal-title":"Health Serv Res."},{"issue":"7","key":"pone.0288777.ref040","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/aje\/kwq472","article-title":"Implementation of G-Computation on a Simulated Data Set: Demonstration of a Causal Inference Technique","volume":"173","author":"JM Snowden","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"4","key":"pone.0288777.ref041","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1214\/13-STS453","article-title":"Standardization and Control for Confounding in Observational Studies: A Historical Perspective.","volume":"29","author":"N Keiding","year":"2014","journal-title":"Stat Sci."},{"issue":"2","key":"pone.0288777.ref042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/oxfordjournals.aje.a009786","article-title":"Factors influencing the optimal control-to-case ratio in matched case-control studies","volume":"149","author":"S Hennessy","year":"1999","journal-title":"Am J Epidemiol"},{"key":"pone.0288777.ref043","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jss.2018.10.020","article-title":"Lack of Cancer Recurrence Data in Large Databases: A National Survey of Hospital Cancer Registries","volume":"235","author":"H In","year":"2019","journal-title":"J Surg Res"},{"key":"pone.0288777.ref044","unstructured":"Statbel. Health index. 2022 [Cited 2022 April 18]; Available from: https:\/\/statbel.fgov.be\/en\/themes\/consumer-prices\/health-index"},{"key":"pone.0288777.ref045","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/j.jval.2018.09.2156","article-title":"PRM33\u2014HUMAN CAPITAL VS. FRICTION COST APPROACH\u2013DIFFERENCES IN THE PRESENCE OF DEATH AND LONG-TERM CONSEQUENCES.","volume":"21","author":"M Steinmann","year":"2018","journal-title":"Value HealthOct 1"},{"issue":"6","key":"pone.0288777.ref046","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40258-018-0416-4","article-title":"Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review.","volume":"16","author":"J Pike","year":"2018","journal-title":"Appl Health Econ Health Policy."},{"key":"pone.0288777.ref047","author":"L. Hakkaart-van Roijen","year":"2010","journal-title":"Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg"},{"key":"pone.0288777.ref048","article-title":"Belgian guidelines for economic evaluations and budget impact analyses: second edition.","author":"I Cleemput","year":"2012","journal-title":"Health Technology Assessment (HTA). KCE [Internet]."},{"issue":"12","key":"pone.0288777.ref049","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40273-015-0309-4","article-title":"Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice.","volume":"33","author":"JF O\u2019Mahony","year":"2015","journal-title":"Pharmacoeconomics."},{"issue":"1","key":"pone.0288777.ref050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices\u2014Modeling Studies.","volume":"6","author":"Weinstein MC","year":"2003","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res.Feb"},{"issue":"5","key":"pone.0288777.ref051","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.","volume":"32","author":"AH Briggs","year":"2012","journal-title":"Med Decis Mak Int J Soc Med Decis Mak.Oct"},{"key":"pone.0288777.ref052","year":"2016","journal-title":"York Health Economics Consortium"},{"issue":"3","key":"pone.0288777.ref053","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jnci\/djab202","article-title":"The Incidence of Breast Cancer Recurrence 10\u201332 Years After Primary Diagnosis","volume":"114","author":"RN Pedersen","year":"2022","journal-title":"JNCI J Natl Cancer Inst"},{"key":"pone.0288777.ref054","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"T Dyba","year":"2021","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"10060","key":"pone.0288777.ref055","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/S0140-6736(16)32235-8","article-title":"The global shortage of health workers-an opportunity to transform care","volume":"388","author":"A Darzi","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"pone.0288777.ref056","author":"House of Commons","year":"2022","journal-title":"NHS backlogs and waiting times in England: Forty-Fourth Report of Session 2021\u201322"},{"key":"pone.0288777.ref057","author":"World Health Organization (WHO).","year":"2022","journal-title":"Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic"},{"key":"pone.0288777.ref058","author":"Rijksinstituut voor Volksgezondheid en Milieu (RIVM)","year":"2020","journal-title":"Impact van de eerste COVID-19 golf op de reguliere zorg en gezondheid"},{"issue":"Suppl 1","key":"pone.0288777.ref059","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-019-0471-3","article-title":"Methodology of the health economic evaluation of the Feel4Diabetes-study.","volume":"20","author":"R Willems","year":"2020","journal-title":"BMC Endocr DisordMar 12"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0306495","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000}},{"DOI":"10.1371\/journal.pone.0295992","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T23:11:24Z","timestamp":1703459484000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288777"}},"subtitle":[],"editor":[{"given":"Matteo","family":"Ruggeri","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288777","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0306495","asserted-by":"object"},{"id-type":"doi","id":"10.1371\/journal.pone.0295992","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}